EVALUATION OF CGA IMPACT ON THE QOL OF ELDERLY PATIENTS AFFECTED BY SOLID AND LIQUID MALIGNANCIES, TREATED WITH TARGET DIRECTED AGENTS OR COMPLEX MULTIMODALITY TREATMENTS